A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma
Analytical Biochemistry · 2023
DOI: 10.1016/j.ab.2023.115230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2023. Verfasst von Yao Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-Sen University, Zhuhai, 519000, China; Institute of Clinical…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Science and Technology Program of Guizhou Province.
Abstract (Originalsprache)
Rapidly developing UHPLC-MS/MS bioassays with high throughput and quality are challenging yet desired in routine clinics. METHODS & RESULTS: A high-throughput UHPLC-MS/MS bioassay has been built for simultaneously quantifying gefitinib, ruxolitinib, dasatinib, imatinib, ibrutinib, methotrexate, cyclophosphamide and paclitaxel. After the protein precipitation with methanol, samples were separated on an Acquity BEH C18 column following a gradient elution system with methanol and 2 mM ammonium acetate in water at 40 °C with a run time of 3 min (flow rate 0.4 mL/min). Mass quantification in the positive ion SRM mode was then performed with electrospray ionization. The method of specificity, linearity, accuracy, precision, matrix effects, recovery, stability, dilution integrity and carryover were all validated as per the guideline of the China Food and Drug Administration whose values met the admissible limits. Application of the bioassay to therapeutic drug monitoring revealed important variability in the studied anti-tumour drugs. CONCLUSION: This validated approach was shown to be reliable and effective in clinical management, being a valuable support in therapeutic drug monitoring and subsequent individualized dosing optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Fifth Affiliated Hospital of Sun Yat-sen University, Sun Yat-Sen University, Zhuhai, 519000, China; Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen Universi…
- Department of Pharmacy, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
- School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.
- The Second Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou, 556000, China.
- The Second Affiliated Hospital of Guizhou Medical University, Kaili, Guizhou, 556000, China; Guangdong RangerBio Technologies Co., Ltd., Dongguan 523000, China. Electronic address: liuq369@mail.sysu.edu.cn.
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China. Electronic address: guanyp6@mail.sysu.edu.cn.
Förderung
- Science and Technology Program of Guizhou Province
Zitieren
APA
Liu, Y., He, Z., Liang, H., Han, M., Wang, J., Liu, Q., & Guan, Y. (2023). A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma. Analytical Biochemistry. https://doi.org/10.1016/j.ab.2023.115230
Vancouver
Liu Y, He Z, Liang H, Han M, Wang J, Liu Q, et al. A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma. Analytical Biochemistry. 2023. doi:10.1016/j.ab.2023.115230
BibTeX
@article{Liu2023,
author = {Liu, Yao and He, Zhichao and Liang, Heng and Han, Minzhen and Wang, Jinxingyi and Liu, Qian and Guan, Yanping},
title = {A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma},
journal = {Analytical Biochemistry},
year = {2023},
doi = {10.1016/j.ab.2023.115230}
}
EUVIMED